Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Parks

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Applied Optics|March 10, 2010
Optical transfer function synthesis: a geometrical optics approachH H Barrett, M Y Chiu, S K Gordon, et al.
Applied Optics|March 24, 2010
Testing of nonlinear diamond-turned reflaxiconsJ Hayes, K L Underwood, J S Loomis, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazepR E Parks, D D Dawicki, K C Agarwal, et al.
The Journal of Biological Chemistry|April 25, 1981
Crystallization and preliminary X-ray investigation of human erythrocytic purine nucleoside phosphorylaseW J Cook, S E Ealick, C E Bugg, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
Biochemical Pharmacology|May 1, 1982
C(2')-substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotidesJ D Stoeckler, C A Bell, R E Parks, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycinF J Cummings, G W Crabtree, M C Wiemann, et al.
Biochemical Pharmacology|May 1, 1979
N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cellsG W Crabtree, R P Agarwal, R E Parks, et al.
Cancer Research|July 1, 1986
Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiationS F Chen, J S Cleaveland, A B Hollmann, et al.
Journal of Medicinal Chemistry|December 1, 1981
Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adeninesG Bastian, M Bessodes, R P Panzica, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Applied Optics|March 10, 2010
Optical transfer function synthesis: a geometrical optics approachH H Barrett, M Y Chiu, S K Gordon, et al.
Applied Optics|March 24, 2010
Testing of nonlinear diamond-turned reflaxiconsJ Hayes, K L Underwood, J S Loomis, et al.
Annals of the New York Academy of Sciences|January 1, 1985
Role of nucleoside transport in drug action. The adenosine deaminase inhibitor, deoxycoformycin, and the antiplatelet drugs, dipyridamole and dilazepR E Parks, D D Dawicki, K C Agarwal, et al.
The Journal of Biological Chemistry|April 25, 1981
Crystallization and preliminary X-ray investigation of human erythrocytic purine nucleoside phosphorylaseW J Cook, S E Ealick, C E Bugg, et al.
Cancer Treatment Reports|April 1, 1986
Mechanism of activation of triciribine phosphate (TCN-P) as a prodrug form of TCNL L Wotring, G W Crabtree, N L Edwards, et al.
Biochemical Pharmacology|May 1, 1982
C(2')-substituted purine nucleoside analogs. Interactions with adenosine deaminase and purine nucleoside phosphorylase and formation of analog nucleotidesJ D Stoeckler, C A Bell, R E Parks, et al.
Clinical Pharmacology and Therapeutics|November 1, 1988
Clinical, pharmacologic, and immunologic effects of 2'-deoxycoformycinF J Cummings, G W Crabtree, M C Wiemann, et al.
Biochemical Pharmacology|May 1, 1979
N-Methylformycins. Reactivity with adenosine deaminase, incorporation into intracellular nucleotides of human erythrocytes and L 1210 cells and cytotoxicity to L 1210 cellsG W Crabtree, R P Agarwal, R E Parks, et al.
Cancer Research|July 1, 1986
Changes in nucleoside transport of HL-60 human promyelocytic cells during N,N-dimethylformamide induced differentiationS F Chen, J S Cleaveland, A B Hollmann, et al.
Journal of Medicinal Chemistry|December 1, 1981
Adenosine deaminase inhibitors. Conversion of a single chiral synthon into erythro- and threo-9-(2-hydroxy-3-nonyl)adeninesG Bastian, M Bessodes, R P Panzica, et al.
Pageof 12